EUVIMEDEUVIMED entdecken
Fallbericht

Malignant glomus tumor arising in association with a fumarate hydratase‐deficient leiomyoma: An unusual collision tumor

Emma L Short iD, Suzanna J Logan, Judith Jebastin Thangaiah, Andrew L Folpe iD

Journal of Cutaneous Pathology · 2024

DOI: 10.1111/cup.14585 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Cutaneous Pathology, 2024. Verfasst von Emma L Short und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cellular Pathology, Morriston Hospital, Swansea, UK. Hauptthemen laut MEDLINE: Glomus Tumor, Uterine Neoplasms, Leiomyomatosis, Carcinoma, Renal Cell. Die Arbeit nennt 11 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Collision tumors, defined as “two independent neoplasms that occur in close proximity to one another but maintain distinct boundaries,” are quite rare. We report an exceptional collision tumor composed of a genetically confirmed malignant glomus tumor and a fumarate hydratase (FH)‐deficient leiomyoma, presenting as a subcutaneous thigh mass in a 38‐year‐old male who was known to have hereditary leiomyomatosis and renal cell carcinoma syndrome. Microscopic examination identified a biphasic subcutaneous mass comprising sheets and nodules of glomus cells, with nuclear atypia and mitotic activity, and fascicles of mitotically inactive smooth muscle with variably pleomorphic nuclei and intracytoplasmic eosinophilic inclusions, features of FH‐deficient leiomyoma. Immunohistochemistry demonstrated loss of FH and robust 2‐succinocysteine expression in the smooth muscle, with a normal (FH‐retained) expression pattern in the glomus tumor. Next‐generation sequencing, performed on the glomus tumor component, identified CARMN::NOTCH2 fusion, characteristic of malignant glomus tumors. Awareness of the distinctive morphologic, immunohistochemical, and molecular genetic features of glomus tumors and FH‐deficient leiomyomas is important for correct clinical management of patients with exceptional collision tumors of this type.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glomus TumorUterine NeoplasmsLeiomyomatosisCarcinoma, Renal CellSarcomaKidney NeoplasmsSkin NeoplasmsMaleFemaleHumansAdultFumarate Hydratase

Stichwörter der Autor:innen

2-succinocysteinecollision tumorfumarate hydrataseglomus tumorhereditary leiomyomatosis and renal cell carcinoma syndromeimmunohistochemistryleiomyomamolecular genetics

Substanzen

Fumarate Hydratase

Autor:innen und Institutionen

  • Department of Cellular Pathology, Morriston Hospital, Swansea, UK.
  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.

ORCID-Profile: Emma L Short, Andrew L Folpe

Zitieren

APA

Short, E. L., Logan, S. J., Thangaiah, J. J., & Folpe, A. L. (2024). Malignant glomus tumor arising in association with a fumarate hydratase‐deficient leiomyoma: An unusual collision tumor. Journal of Cutaneous Pathology. https://doi.org/10.1111/cup.14585

Vancouver

Short EL, Logan SJ, Thangaiah JJ, Folpe AL. Malignant glomus tumor arising in association with a fumarate hydratase‐deficient leiomyoma: An unusual collision tumor. Journal of Cutaneous Pathology. 2024. doi:10.1111/cup.14585

BibTeX
@article{Short2024,
  author = {Short, Emma L and Logan, Suzanna J and Thangaiah, Judith Jebastin and Folpe, Andrew L},
  title = {Malignant glomus tumor arising in association with a fumarate hydratase‐deficient leiomyoma: An unusual collision tumor},
  journal = {Journal of Cutaneous Pathology},
  year = {2024},
  doi = {10.1111/cup.14585}
}
Kostenlos starten →